What is Veterinary Infectious Disease Diagnostics Market Scope?
Growing demand for advanced diagnostic devices, rising demand for animal-derived food products, growth in companion animal population, increasing number of veterinary practitioners, and increasing disease control and disease prevention measures are the major key drivers fueling the growth of the market. Veterinary infectious disease is growing rapidly across the globe, which is propelling the demand for diagnostics.
The Veterinary Infectious Disease Diagnostics market study is being classified and major geographies with country level break-up.
Analysts at AMA predicts that Players from United States will contribute to the maximum growth of United States Veterinary Infectious Disease Diagnostics market throughout the predicted period.
Heska Corporation (United States), IDEXX Laboratories, Inc. (United States), Neogen Corporation (United States), Zoetis, Inc. (United States), QIAGEN N.V. (A Part of Indical Bioscience (Germany), Randox Laboratories, Ltd. (United Kingdom), Thermo Fisher Scientific (United States), Biomerieux S.A. (France), IDVet (France) and Virbac (France) are some of the key players profiled in the study.
Segmentation Analysis
Analyst at AMA have segmented the market study of United States Veterinary Infectious Disease Diagnostics market by Type, Application and Region.
On the basis of geography, the market of Veterinary Infectious Disease Diagnostics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On 12 April 2017, Zoetis announced the launch of Witness Lepto, a rapid, point-of-care test available in the United States that detects the primary immune response to canine leptospires as early as seven days after infection. Witness Lepto is the first point-of-care test available in the United States for specific detection of anti-Lepstospira immunoglobulin M (IgM) antibodies to four of the most common serovars — Canicola, Grippotyphosa, Icterohaemorrhagiae and Pomona — affecting dogs.
Influencing Market Trend
- Increasing Vegan Population
- Adoption of Web Monitoring and Other Digital Aids to Detect Emerging Animal Infectious Diseases
Market Drivers
- Growing Demand for Advanced Diagnostic Devices
- Rising Demand for Animal-Derived Food Products
- Growth in Companion Animal Population
- Rising Demand for Pet Insurance
Opportunities
- Increasing Disease Control and Disease Prevention Measures
Restraints
- Increasing Pet Care Costs
Key Target Audience
1.12 Key Target Audience, Veterinary Infectious Disease Diagnostics Companies, Veterinary Clinics & Hospitals, Regulatory & Government Bodies, Research & Consulting Firms, Universities, Upstream & Downstream Vendors, End Users and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.